Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
124.34 USD
-9.91%
Market Closed
Updated:
Apr 27, 2024
Dexcom Inc
Operating Expenses
|
Dexcom Inc
Operating Expenses Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Operating Expenses
-$1.7B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-29%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$7.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$8.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$15.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
See Also
What is Dexcom Inc's Operating Expenses?
Operating Expenses
-1.7B
USD
-1.7B
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Operating Expenses amounts to -1.7B USD.
What is Dexcom Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-29%
-29%
Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for Dexcom Inc have been -20% over the past three years , -15% over the past five years , and -29% over the past ten years .
You don't have any saved screeners yet
